We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-5.94%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.24B
AUM Growth
-$312M
Cap. Flow
+$100M
Cap. Flow %
1.91%
Top 10 Hldgs %
19.63%
Holding
588
New
50
Increased
219
Reduced
167
Closed
31

Top Sells

Rank Stock Value
1
FL
Foot Locker
FL
+$42.5M
2
WMT icon
Walmart Inc
WMT
+$15.2M
3
JPM icon
JPMorgan Chase
JPM
+$14.9M
4
ENOV icon
Enovis
ENOV
+$14.8M
5
PH icon
Parker-Hannifin
PH
+$12.7M

Sector Composition

Rank Sector Weight
1 Technology 31.7%
2 Healthcare 18.75%
3 Consumer Discretionary 11.87%
4 Financials 9.73%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSI icon
276
iShares MSCI KLD 400 Social ETF
DSI
$5.52B
$2.41M 0.05%
27,826
+194
+0.7% +$16.6K
NTES icon
277
NetEase
NTES
$82B
$2.39M 0.05%
26,000
ETSY icon
278
Etsy
ETSY
$8.15B
$2.37M 0.05%
18,280
+3,734
+26% +$555K
ONC
279
BeOne Medicines Ltd
ONC
$36.4B
$2.27M 0.04%
11,000
-1,500
-12% -$319K
LULU icon
280
lululemon athletica
LULU
$14B
$2.23M 0.04%
6,167
+660
+12% +$215K
SWKS icon
281
Skyworks Solutions
SWKS
$10.1B
$2.22M 0.04%
16,635
+1,660
+11% +$233K
ACAD icon
282
Acadia Pharmaceuticals
ACAD
$4.96B
$2.21M 0.04%
90,600
-10,900
-11% -$264K
TJX icon
283
TJX Companies
TJX
$177B
$2.2M 0.04%
35,530
-870
-2% -$58.3K
NBIX icon
284
Neurocrine Biosciences
NBIX
$16.4B
$2.2M 0.04%
23,800
-1,100
-4% -$93.2K
CTSH icon
285
Cognizant
CTSH
$25.1B
$2.19M 0.04%
24,000
SNOW icon
286
Snowflake
SNOW
$110B
$2.17M 0.04%
9,377
+383
+4% +$99K
RBLX icon
287
Roblox
RBLX
$25.9B
$2.17M 0.04%
45,000
+2,000
+5% +$121K
MRTX
288
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.1M 0.04%
25,200
EPP icon
289
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
$2.08M 0.04%
42,210
-7,200
-15% -$340K
MELI icon
290
Mercado Libre
MELI
$97.5B
$2.07M 0.04%
1,708
-90
-5% -$97.9K
ARGX icon
291
argenx
ARGX
$54.3B
$2.04M 0.04%
6,500
ALL icon
292
Allstate
ALL
$68.1B
$2.04M 0.04%
14,500
-2,000
-12% -$251K
GBT
293
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.03M 0.04%
58,000
+4,500
+8% +$135K
JNPR
294
DELISTED
Juniper Networks
JNPR
$2.01M 0.04%
53,500
+16,000
+43% +$550K
GPN icon
295
Global Payments
GPN
$23.9B
$1.97M 0.04%
14,343
+2,289
+19% +$320K
AAON icon
296
Aaon
AAON
$7.63B
$1.97M 0.04%
52,997
+8,129
+18% +$331K
DE icon
297
Deere & Co
DE
$165B
$1.97M 0.04%
4,735
+116
+3% +$44.5K
WU icon
298
Western Union
WU
$2.26B
$1.96M 0.04%
101,900
+32,000
+46% +$592K
AME icon
299
Ametek
AME
$58.4B
$1.94M 0.04%
14,300
+7,600
+113% +$1.02M
HALO icon
300
Halozyme
HALO
$9.87B
$1.92M 0.04%
47,800
-5,900
-11% -$210K

Similar funds

Erste Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Erste Asset Management held 588 positions worth $5.24B, down 5.6% from $5.55B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Erste Asset Management's Q1 2022 filing shows 50 new, 219 increased, 167 reduced and 31 closed positions. Its largest new stake was Houghton Mifflin Harcourt Company: 920,000 shares worth $19.3M. The largest sale was Foot Locker, an estimated $42.5M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q1 2022 buy was Houghton Mifflin Harcourt Company: 920,000 shares worth $19.3M.
  • Erste Asset Management added most to Pfizer in Q1 2022, an estimated $26.5M increase.
  • Erste Asset Management's biggest Q1 2022 reduction was Walmart Inc, cutting an estimated $15.2M.
  • Erste Asset Management fully exited Foot Locker in Q1 2022, selling an estimated $42.5M.
  • Erste Asset Management's ten largest holdings make up 20% of its $5.24B portfolio in Q1 2022.
  • Erste Asset Management opened 50 new positions and closed 31 in Q1 2022.
  • Erste Asset Management's portfolio value fell 5.6% quarter-over-quarter to $5.24B.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.